The Safety and Immunological Effects of rAd5-EBV-LMP2 Vaccine in Nasopharyngeal Carcinoma Patients: A Phase I Clinical Trial and Two-Year Follow-UpYongfeng Si, Ying Qin, Jiazhang Wei et al.|Chemical and Pharmaceutical Bulletin|2016Cited by 49
[Treatment and outcome of recurrent cervical lymph nodes in patients with nasopharyngeal carcinoma after radiotherapy].Yongli Wang, Fuling Zhou, Guiping Lan et al.|PubMed|2016Cited by 2
Analysis of EB virus LMP2 specific immune status among three groups in Guangxi areaZhuoxia Deng, Xing Han, Yang Yong et al.|Chinese Journal of Clinical Hepatology|2016Cited by 0